Arqit Quantum (ARQQ) CFO details RSUs, options and shares

Rhea-AI Filing Summary

Arqit Quantum Inc. Chief Financial Officer Nicholas Pointon filed an initial ownership report showing his equity interests in the company. He holds 11,902 ordinary shares directly, multiple grants of restricted stock units that each represent a right to one ordinary share and vest in quarterly installments from April 1, 2026 through October 1, 2028, and 3,066 employee share options to buy ordinary shares at an exercise price of $0.0025 per share, expiring on March 1, 2031, most of which have already vested.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider Pointon Nicholas

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Restricted Stock Units	--	--	--
holding	Restricted Stock Units	--	--	--
holding	Restricted Stock Units	--	--	--
holding	Restricted Stock Units	--	--	--
holding	Employee Share Options (right to buy)	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Restricted Stock Units — 14,578 shares (Direct); Employee Share Options (right to buy) — 3,066 shares (Direct); Ordinary Shares — 11,902 shares (Direct)

Footnotes (1)

1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one ARQQ ordinary share. The RSUs vest quarterly in equal installments on April 1, July 1, and October 1, 2026, and January 1, April 1, July 1, and October 1, 2027. Each RSU represents a contingent right to receive one ARQQ ordinary share. The RSUs vest quarterly in equal installments on April 1, and July 1, 2026. Each RSU represents a contingent right to receive one ARQQ ordinary share. The RSUs vest quarterly in equal installments on April 1, July 1, and October 1, 2026, and January 1, April 1, and July 1, 2027. Each RSU represents a contingent right to receive one ARQQ ordinary share. 501 RSUs vest on April 1, 2026 and the remaining RSUs vest quarterly in equal installments on July 1, and October 1, 2026, and January 1, April 1, July 1, and October 1, 2027, and January 1, April 1, July 1, and October 1, 2028. Each Employee Share Option can be exercised at any time after vesting, at the holder's election, to purchase one ARQQ ordinary share. 2,560 Employee Share Options have already vested. The remaining 506 Employee Share Options will vest on March 31, 2026.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Pointon Nicholas

(Last) (First) (Middle)

C/O ARQIT INC.

1209 ORANGE STREET

(Street)

WILMINGTON DELAWARE 19801

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Arqit Quantum Inc. [ ARQQ ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	11,902	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	(1)	Ordinary Shares	14,578	(1)	D
Restricted Stock Units	(2)	(2)	Ordinary Shares	206	(2)	D
Restricted Stock Units	(3)	(3)	Ordinary Shares	2,414	(3)	D
Restricted Stock Units	(4)	(4)	Ordinary Shares	9,064	(4)	D
Employee Share Options (right to buy)	(5)	03/01/2031	Ordinary Shares	3,066	$0.0025	D

Explanation of Responses:

1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one ARQQ ordinary share. The RSUs vest quarterly in equal installments on April 1, July 1, and October 1, 2026, and January 1, April 1, July 1, and October 1, 2027.

2. Each RSU represents a contingent right to receive one ARQQ ordinary share. The RSUs vest quarterly in equal installments on April 1, and July 1, 2026.

3. Each RSU represents a contingent right to receive one ARQQ ordinary share. The RSUs vest quarterly in equal installments on April 1, July 1, and October 1, 2026, and January 1, April 1, and July 1, 2027.

4. Each RSU represents a contingent right to receive one ARQQ ordinary share. 501 RSUs vest on April 1, 2026 and the remaining RSUs vest quarterly in equal installments on July 1, and October 1, 2026, and January 1, April 1, July 1, and October 1, 2027, and January 1, April 1, July 1, and October 1, 2028.

5. Each Employee Share Option can be exercised at any time after vesting, at the holder's election, to purchase one ARQQ ordinary share. 2,560 Employee Share Options have already vested. The remaining 506 Employee Share Options will vest on March 31, 2026.

Remarks:

Due to the issuer's status as a foreign private issuer pursuant to Rule 3a12-3(b) under the Securities Exchange Act of 1934 (the "Act"), the reporting person's transactions in the issuer's securities are exempt from Sections 16(b) and 16(c) of the Act. Ex. 24 - Power of Attorney

	/s/ Nicholas Pointon	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Arqit Quantum (ARQQ) Form 3 filing show for CFO Nicholas Pointon?

The Form 3 shows CFO Nicholas Pointon’s existing equity holdings in Arqit Quantum, including ordinary shares, restricted stock units, and employee share options. It establishes his baseline ownership as he becomes a reporting insider under SEC rules.

How many Arqit Quantum (ARQQ) ordinary shares does the CFO directly own?

Nicholas Pointon directly owns 11,902 ordinary shares of Arqit Quantum. This position is reported as part of his initial insider ownership and sits alongside additional equity awards in the form of restricted stock units and employee share options.

What restricted stock units are reported for the Arqit Quantum (ARQQ) CFO?

The filing lists several restricted stock unit awards, each representing a contingent right to receive one ordinary share. These RSUs vest in scheduled quarterly installments beginning April 1, 2026 and continuing through various dates up to October 1, 2028, as specified in the footnotes.

What employee share options does the Arqit Quantum (ARQQ) CFO hold?

The CFO holds 3,066 employee share options, each allowing purchase of one ordinary share at an exercise price of $0.0025 per share. According to the footnotes, 2,560 options have already vested and the remaining 506 will vest on March 31, 2026.

Do the Arqit Quantum (ARQQ) RSUs for the CFO have a vesting schedule?

Yes. The RSUs vest quarterly, with specific series vesting on dates including April 1, July 1, and October 1, 2026, and further installments on January 1, April 1, July 1, October 1, 2027, and selected dates in 2028, as detailed in multiple footnotes.

Does the Arqit Quantum (ARQQ) Form 3 reflect any insider buying or selling by the CFO?

No explicit buying or selling transactions are shown. The entries are reported as holdings, indicating the equity positions and awards Nicholas Pointon beneficially owns, rather than market purchases or sales of Arqit Quantum ordinary shares.